StockData
Octave Specialty Group Inc logo

Octave Specialty Group Inc (OSG) stock

OSGNYSESurety InsuranceFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.95−0.37 (-6.95%)

Close on Nov 17, 2026Market cap $223.01MP/E –Yield –

Octave Specialty total assets

Total assets on the balance sheet at the end of each period.

Octave Specialty's total assets was $2.28B at Jun 30, 2026. For fiscal 2025 it was $2.22B, down 72.4% from the year before. Over ten years it grew -22.1% a year on average. The highest annual figure on record is $29.05B in fiscal 2010.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.22B-72.4%
FY2024Dec 31, 2024$8.06B-4.4%
FY2023Dec 31, 2023$8.43B+5.7%
FY2022Dec 31, 2022$7.97B-35.2%
FY2021Dec 31, 2021$12.30B-6.9%
FY2020Dec 31, 2020$13.22B-0.8%
FY2019Dec 31, 2019$13.32B-8.7%
FY2018Dec 31, 2018$14.59B-37.1%
FY2017Dec 31, 2017$23.19B-14.4%
FY2013Dec 31, 2013$27.09B+0.0%
FY2012Dec 31, 2012$27.09B-0.1%
FY2011Dec 31, 2011$27.11B-6.7%
FY2010Dec 31, 2010$29.05B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.28B-73.2%
Q1 FY2026Mar 31, 2026$2.27B-72.5%
Q4 FY2025Dec 31, 2025$2.22B-72.4%
Q3 FY2025Sep 30, 2025$2.15B-76.8%
Q2 FY2025Jun 30, 2025$8.52B+4.1%
Q1 FY2025Mar 31, 2025$8.25B-2.1%
Q4 FY2024Dec 31, 2024$8.06B-4.4%
Q3 FY2024Sep 30, 2024$9.26B+18.0%
Q2 FY2024Jun 30, 2024$8.18B+0.6%
Q1 FY2024Mar 31, 2024$8.43B+2.6%
Q4 FY2023Dec 31, 2023$8.43B+5.7%
Q3 FY2023Sep 30, 2023$7.85B-16.6%
Q2 FY2023Jun 30, 2023$8.13B-19.2%
Q1 FY2023Mar 31, 2023$8.22B-28.7%
Q4 FY2022Dec 31, 2022$7.97B-35.2%
Q3 FY2022Sep 30, 2022$9.41B-23.0%
Q2 FY2022Jun 30, 2022$10.06B-22.1%
Q1 FY2022Mar 31, 2022$11.53B-10.2%
Q4 FY2021Dec 31, 2021$12.30B-6.9%
Q3 FY2021Sep 30, 2021$12.23B-4.2%
Q2 FY2021Jun 30, 2021$12.91B+1.0%
Q1 FY2021Mar 31, 2021$12.84B-3.6%
Q4 FY2020Dec 31, 2020$13.22B-1.7%
Q2 FY2020Jun 30, 2020$12.76B-13.3%
Q3 FY2020Mar 31, 2020$12.78B-14.9%
Q4 FY2019Dec 31, 2019$13.32B-8.7%
Q3 FY2019Sep 30, 2019$13.45B-42.0%
Q2 FY2019Jun 30, 2019$14.71B-44.7%
Q1 FY2019Mar 31, 2019$15.02B–
Q4 FY2018Dec 31, 2018$14.59B–
Q4 FY2017Dec 31, 2017$23.19B–
Q3 FY2014Sep 30, 2014$26.59B–

More Octave Specialty figures

See a number that looks wrong?